MICROPORT CARDIOFLOW MEDTECH CORP financial statements, including revenue, expenses, profit, and loss
The total revenue of 2160 for the last semiannual is 172.61 M HKD, and it's 13.50% lower compared to the previous semiannual. The net income of H2 23 is -315.60 M HKD.